Treatment of nondermatophyte mold and Candida onychomycosis

Dermatologic Clinics

Volumn 21, Issue 3, 2003, Pages 491-497

  Tosti, Antonella ^a   Piraccini, Bianca Maria ^a   Lorenzi, Sandra ^a   Iorizzo, Matilde ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; CICLOPIROXOLAMINE; FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ASPERGILLUS; CANDIDA; DERMATOPHYTE; ERADICATION THERAPY; HUMAN; MOULD; ONYCHOMYCOSIS; PARONYCHIA; PRIORITY JOURNAL; RELAPSE; REVIEW; SCOPULARIOPSIS BREVICAULIS;

EID: 0042515002     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(03)00036-6     Document Type: Review

References (15)

1. Kiraz M, Yegenoglu Y, Erturan Z, et al. The epidemiology of onychomycoses in Istanbul. Turkey. Mycoses 1999;42:323-9.
2. Kam KM, Au WF, Wong PY, et al. Onychomycosis in Hong Kong. Int J Dermatol 1997;36:757-61.
3. Rigopoulos D, Katsiboulas V, Koumantaki E, et al. Epidemiology of onychomycosis in southern Greece. Int J Dermatol 1998;37:925-8.
4. Gianni C, Cerri A, Crosti C. Non-dermatophytic onychomycosis. An underestimated entity? A study of 51 cases. Mycoses 2000;43:29-33.
5. Heikkila H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995;133:699-703.
6. Baran R, Hay R, Haneke E, et al. Onychomycosis: the current approach to diagnosis and therapy. London: Martin Dunitz; 1999.
7. Piraccini BM, Lorenzi S, Tosti A. Deep white superficial onychomycosis due to moulds. J Eur Acad Dermatol Venereol 2002;16:532-3.
8. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by non-dermatophytic moulds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000;42(2 pt 1):217-24.
9. Gupta AK, Gregurek-Novak T, Konnikov N, et al. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. J Cutan Med Surg 2001; 5:206-10.
10. De Doncker PR, Scher RK, Baran R, et al. Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients. J Am Acad Dermatol 1997; 36(2 pt 1):173-7.
11. Downs L, Downs A. Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer. Br J Dermatol 1999;140:555.
12. Gupta AK, Horgan-Bell CB, Summerbell RC. Onychomycosis associated with Onychocola canadensis: ten case reports and a review of the literature. J Am Acad Dermatol 1998;39:410-7.
13. Tosti A, Piraccini BM, Ghetti E, et al. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double blind and double dummy study. J Am Acad Dermatol 2002; 147:73-6.
14. Tosti A, Piraccini BM, Vincenzi C, et al. Itraconazole in the treatment of two young brothers with chronic mucocutaneous candidiasis. Pediatr Dermatol 1997;14: 146-8.
15. Tosti A, Piraccini BM, Lorenzi S, et al. Candida onychomycosis in HIV infection. Eur J Dermatol 1998; 8:173-4.